Clinical trials in Salgotarjan

Innovative clinical trials focusing on hormone receptor-positive and HER2-negative breast cancer treatments, including studies of novel therapeutic combinations and targeted therapies.

• Advanced metastatic breast cancer treatments
• Triple-negative breast cancer therapies
• Hormone therapy resistance studies

Research includes evaluation of new drug combinations and sequential therapy approaches for improved patient outcomes.

Groundbreaking research on non-small cell lung cancer treatments, particularly focusing on advanced and metastatic cases with specific biomarker profiles.

• PD-L1 positive NSCLC treatments
• Combination immunotherapy approaches
• Stage III unresectable cancer therapies

Studies emphasize personalized treatment approaches based on molecular markers.

Clinical trials investigating new treatments for head and neck squamous cell carcinoma, including both HPV-negative and recurrent/metastatic cases.

• Novel combination therapies
• Immunotherapy applications
• Treatment for recurrent disease

Research focuses on improving survival rates through innovative therapeutic combinations.

Studies addressing metastatic castration-resistant prostate cancer, evaluating new treatment options and therapeutic combinations.

• Novel hormonal therapies
• Treatment-resistant cases
• Combination therapy approaches

Trials aim to improve outcomes for patients with advanced disease stages.

Studies examining treatments for cardiovascular diseases and related conditions, including stroke prevention and obesity management.

• Acute ischemic stroke treatments
• Obesity management in CVD patients
• Prevention strategies

Research focuses on both therapeutic interventions and preventive approaches.